ARTICLE | Clinical News
TeaRxaban: Phase II started
January 27, 2014 8:00 AM UTC
TeaRx began a Russian Phase II trial to compare TeaRxaban vs. enoxaparin in patients undergoing knee replacement surgery. The company has exclusive rights to develop and commercialize the compound in ...